Havens Advisors buys $6,665,100 stake in Monsanto Company (MON)

Monsanto Company (MON) : Havens Advisors scooped up 43,300 additional shares in Monsanto Company during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Oct 13, 2016. The investment management firm now holds a total of 65,000 shares of Monsanto Company which is valued at $6,665,100.Monsanto Company makes up approximately 5.33% of Havens Advisors’s portfolio.

Other Hedge Funds, Including , Capstone Asset Management Co boosted its stake in MON in the latest quarter, The investment management firm added 1,692 additional shares and now holds a total of 31,379 shares of Monsanto Company which is valued at $3,242,392. Monsanto Company makes up approx 0.09% of Capstone Asset Management Co’s portfolio. Prospera Financial Services Inc added MON to its portfolio by purchasing 2,440 company shares during the most recent quarter which is valued at $252,125. Monsanto Company makes up approx 0.05% of Prospera Financial Services Inc’s portfolio.Carroll Financial Associates boosted its stake in MON in the latest quarter, The investment management firm added 278 additional shares and now holds a total of 4,336 shares of Monsanto Company which is valued at $446,478. Monsanto Company makes up approx 0.07% of Carroll Financial Associates’s portfolio.Telemus Capital reduced its stake in MON by selling 279 shares or 5.91% in the most recent quarter. The Hedge Fund company now holds 4,445 shares of MON which is valued at $458,635. Monsanto Company makes up approx 0.05% of Telemus Capital’s portfolio.

Monsanto Company opened for trading at $102.7 and hit $103.49 on the upside on Tuesday, eventually ending the session at $103.33, with a gain of 0.35% or 0.36 points. The heightened volatility saw the trading volume jump to 18,03,877 shares. Company has a market cap of $45,215 M.

On the company’s financial health, Monsanto Company reported $0.07 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on Oct 5, 2016. Analyst had a consensus of $-0.03. The company had revenue of $2562.00 million for the quarter, compared to analysts expectations of $2379.03 million. The company’s revenue was up 8.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.19 EPS.

Many Wall Street Analysts have commented on Monsanto Company. Shares were Reiterated by Monness Crespi & Hardt on Oct 3, 2016 to “Buy” and Lowered the Price Target to $ 128 from a previous price target of $130 .Monsanto Company was Upgraded by Goldman to ” Neutral” on Sep 27, 2016. Monsanto Company was Upgraded by Bernstein to ” Mkt Perform” on Sep 26, 2016.

Monsanto Company (Monsanto) is a provider of agricultural products for farmers. The Company’s seeds biotechnology trait products and herbicides provide farmers with solutions that improve productivity reduce the costs of farming and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics and Agricultural Productivity. Through its Seeds and Genomics segment it produces seed brands including DEKALB Asgrow Deltapine Seminis and De Ruiter and it develops biotechnology traits that assist farmers in controlling insects and weeds. Through its Agricultural Productivity segment it manufactures Roundup brand herbicides and other herbicides and provides lawn-and-garden herbicide products for the residential market.

Leave a Reply

Monsanto Company - Is it time to Sell?

Top Brokerage Firms are advising their investors on Monsanto Company. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.